These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10908271)

  • 1. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.
    Abrams D; Schulze-Neick I; Magee AG
    Heart; 2000 Aug; 84(2):E4. PubMed ID: 10908271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil treatment of primary pulmonary hypertension.
    Laupland KB; Helmersen D; Zygun DA; Viner SM
    Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil as a treatment for pulmonary hypertension.
    Carroll WD; Dhillon R
    Arch Dis Child; 2003 Sep; 88(9):827-8. PubMed ID: 12937112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol.
    Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S
    Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
    Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
    Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil in the management of primary pulmonary hypertension.
    Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U
    Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

  • 9. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of rebound pulmonary hypertension: why not sildenafil?
    Raja SG
    Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
    [No Abstract]   [Full Text] [Related]  

  • 11. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sildenafil in the treatment of pulmonary hypertension].
    García Martínez E; Ibarra de la Rosa I; Pérez Navero JL; Tejero Mateo I; Expósito Montes JF; Suárez de Lezo y Cruz Conde J
    An Pediatr (Barc); 2003 Jul; 59(1):110-3. PubMed ID: 12887879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
    Jue VI
    Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
    Sastry BK; Narasimhan C; Reddy NK; Raju BS
    J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.
    Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K
    Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
    Derchi G; Forni GL
    Ann N Y Acad Sci; 2005; 1054():471-5. PubMed ID: 16339700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hopes and experiences in the treatment of severe pulmonary hypertension].
    Monserrat L; Penas Lado M; Castro-Beiras A
    Rev Esp Cardiol; 2003 Mar; 56(3):228-9. PubMed ID: 12622951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.